Dixon Hubard Feinour & Brown’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-7,670
| Closed | -$206K | – | 202 |
|
|
2017
Q4 | $206K | Buy |
+7,670
| New | +$206K | 0.06% | 179 |
|
|
2016
Q4 | – | Sell |
-11,640
| Closed | -$242K | – | 180 |
|
|
2016
Q3 | $242K | Sell |
11,640
-430
| -4% | -$8.94K | 0.08% | 149 |
|
|
2016
Q2 | $325K | Hold |
12,070
| – | – | 0.1% | 131 |
|
|
2016
Q1 | $337K | Sell |
12,070
-2,500
| -17% | -$69.8K | 0.11% | 131 |
|
|
2015
Q4 | $423K | Buy |
14,570
+520
| +4% | +$15.1K | 0.13% | 118 |
|
|
2015
Q3 | $381K | Buy |
14,050
+1,388
| +11% | +$37.6K | 0.14% | 116 |
|
|
2015
Q2 | $347K | Sell |
12,662
-3,788
| -23% | -$104K | 0.11% | 130 |
|
|
2015
Q1 | $439K | Hold |
16,450
| – | – | 0.13% | 121 |
|
|
2014
Q4 | $348K | Buy |
16,450
+2,200
| +15% | +$46.5K | 0.11% | 132 |
|
|
2014
Q3 | $339K | Buy |
14,250
+3,880
| +37% | +$92.3K | 0.11% | 132 |
|
|
2014
Q2 | $239K | Hold |
10,370
| – | – | 0.08% | 172 |
|
|
2014
Q1 | $237K | Buy |
+10,370
| New | +$237K | 0.08% | 167 |
|